A variable fraction (12‐30%) of NSCLC patients presents activating mutations in the epidermal growth factor receptor gene (EGFR) (Lynch et al,2004; Paez et al,2004; Pao et al,2004; Wang et al,2011; Zhang et al,2016). Here, EGFR is linked to non-small cell lung carcinoma.